Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
@jsnow1111, well we had 90% move up on pre market today
Nayo305
⋅
Bro correct me if I'm wrong. I just started a couple of months ago. I'm def into leaning how to analyze charts, trade, make a side hustle living with this. Now, with the ticker SONN it seems undervalue at the moment in the Daily time frame? Like oversold. It looks to me is a great time to buy and go long!???